Financing, Equity Capital Markets
Cogent Biosciences
06/22
|
$172.6 Million
Âé¶¹´«Ã½ served as bookrunner for Cogent Biosciences, Inc. on a follow-on offering
Sub-Type
Follow-On Offering
Sector
Sub-Sector
Biopharma